Outlook Therapeutics
OTLK
OTLK
54 hedge funds and large institutions have $2.21M invested in Outlook Therapeutics in 2026 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 15 increasing their positions, 6 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
2% more funds holding
Funds holding: 53 → 54 (+1)
80% less capital invested
Capital invested by funds: $10.8M → $2.21M (-$8.57M)
Holders
54
Holding in Top 10
–
Calls
$79K
Puts
$33K
Top Buyers
| 1 | +$1.8M | |
| 2 | +$154K | |
| 3 | +$124K | |
| 4 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$119K |
| 5 |
Renaissance Technologies
New York
|
+$110K |
Top Sellers
| 1 | -$3.86M | |
| 2 | -$472K | |
| 3 | -$260K | |
| 4 |
SC
Scotia Capital
Toronto,
Ontario, Canada
|
-$117K |
| 5 |
LA
LVW Advisors
Pittsford,
New York
|
-$76.2K |
